UCB's Next Generation Drugs Take Over After Blockbuster Expiry

Published November 12, 2012

UCB's next generation drugs take over after blockbuster expiry

Filed under: Drug Treatment Help Chicago

UCB, which makes drugs targeted at diseases of the immune and central nervous systems, said on Monday sales of Cimzia, Neupro and Vimpat rose 50 percent to 665 million euros over the first nine months and were now treating about 382,000 patients.
Read more on Chicago Tribune

Illinois Medicaid, manufacturer settle lawsuit over premature birth drug

Filed under: Drug Treatment Help Chicago

St. Louis-based KV Pharmaceutical Co. sued the head of the Illinois Department of Healthcare and Family Services in August in U.S. District Court in Chicago, alleging the department was unfairly blocking Medicaid patients' access to Makena. Makena is …
Read more on Crain’s Chicago Business